| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $105.5M | -4.6% |
| Cost of Revenue | $58.7M | +20.3% |
| Gross Profit | $46.8M | -24.2% |
| R&D Expense | $25.9M | -7.5% |
| SG&A Expense | $92.0M | -0.4% |
| Operating Income | -$101.7M | -73.6% |
| Pre-tax Income | -$96.6M | -67.4% |
| Income Tax | $65K | +280.6% |
| Net Income | -$96.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $338.7M | -14.6% |
| Accounts Receivable | $19.0M | -20.0% |
| Inventory | $16.8M | -24.4% |
| Current Assets | $381.4M | -15.0% |
| Total Assets | $434.2M | -13.4% |
| Current Liabilities | $31.0M | -16.3% |
| Total Liabilities | $75.3M | +24.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$48.3M | -0.8% |
| Capital Expenditures | $11.7M | -13.9% |
| Investing Cash Flow | -$11.2M | -76.8% |
| Financing Cash Flow | $2.3M | -99.1% |
| Free Cash Flow | -$60.0M | +2.5% |
| -67.6% |
| EPS (Basic) | -$2.61 | -63.1% |
| EPS (Diluted) | -$2.61 | -63.1% |
| Stockholders' Equity |
| $358.9M |
| -18.6% |